TY - JOUR AU - Currier, J. S. AU - Lundgren, J. D. AU - Carr, A. AU - Klein, D. AU - Sabin, C. A. AU - Sax, P. E. PY - 2008 DA - 2008// TI - Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy JO - Circulation VL - 118 UR - https://doi.org/10.1161/CIRCULATIONAHA.107.189624 DO - 10.1161/CIRCULATIONAHA.107.189624 ID - Currier2008 ER - TY - JOUR AU - Currier, J. S. AU - Taylor, A. AU - Boyd, F. AU - Dezii, C. M. AU - Kawabata, H. AU - Burtcel, B. PY - 2003 DA - 2003// TI - Coronary heart disease in HIV-infected individuals JO - J Acquir Immune Defic Syndr VL - 33 UR - https://doi.org/10.1097/00126334-200308010-00012 DO - 10.1097/00126334-200308010-00012 ID - Currier2003 ER - TY - JOUR AU - Triant, V. A. AU - Lee, H. AU - Hadigan, C. AU - Grinspoon, S. K. PY - 2007 DA - 2007// TI - Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease JO - J Clin Endocrinol Metab VL - 92 UR - https://doi.org/10.1210/jc.2006-2190 DO - 10.1210/jc.2006-2190 ID - Triant2007 ER - TY - JOUR AU - Klein, D. AU - Hurley, L. B. AU - Quesenberry, C. P. AU - Sidney, S. PY - 2002 DA - 2002// TI - Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? JO - J Acquir Immune Defic Syndr VL - 30 UR - https://doi.org/10.1097/00126334-200208150-00002 DO - 10.1097/00126334-200208150-00002 ID - Klein2002 ER - TY - JOUR AU - Bavinger, C. AU - Bendavid, E. AU - Niehaus, K. AU - Olshen, R. A. AU - Olkin, I. AU - Sundaram, V. PY - 2013 DA - 2013// TI - Risk of cardiovascular disease from antiretroviral therapy for HIV: a systematic review JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0059551 DO - 10.1371/journal.pone.0059551 ID - Bavinger2013 ER - TY - JOUR AU - Friis-Moller, N. AU - Reiss, P. AU - Sabin, C. A. AU - Weber, R. AU - Monforte, A. PY - 2007 DA - 2007// TI - Class of antiretroviral drugs and the risk of myocardial infarction JO - N Engl J Med VL - 356 UR - https://doi.org/10.1056/NEJMoa062744 DO - 10.1056/NEJMoa062744 ID - Friis-Moller2007 ER - TY - JOUR AU - Monforte, A. AU - Reiss, P. AU - Ryom, L. AU - El-Sadr, W. AU - Dabis, F. AU - Wit, S. PY - 2013 DA - 2013// TI - Atazanavir is not associated with an increased risk in cardio- or cerebrovascular disease events JO - AIDS VL - 27 UR - https://doi.org/10.1097/QAD.0b013e32835b2ef1 DO - 10.1097/QAD.0b013e32835b2ef1 ID - Monforte2013 ER - TY - JOUR AU - Stein, J. H. AU - Ribaudo, H. J. AU - Hodis, H. N. AU - Brown, T. T. AU - Tran, T. T. AU - Yan, M. PY - 2015 DA - 2015// TI - A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness JO - AIDS VL - 29 UR - https://doi.org/10.1097/QAD.0000000000000762 DO - 10.1097/QAD.0000000000000762 ID - Stein2015 ER - TY - JOUR AU - Metcalfe, A. AU - Neudam, A. AU - Forde, S. AU - Liu, M. AU - Drosler, S. AU - Quan, H. PY - 2013 DA - 2013// TI - Case definitions for acute myocardial infarction in administrative databases and their impact on in-hospital mortality rates JO - Health Serv Res VL - 48 UR - https://doi.org/10.1111/j.1475-6773.2012.01440.x DO - 10.1111/j.1475-6773.2012.01440.x ID - Metcalfe2013 ER - TY - JOUR AU - Roumie, C. L. AU - Mitchel, E. AU - Gideon, P. S. AU - Varas-Lorenzo, C. AU - Castellsaque, J. AU - Griffin, M. R. PY - 2008 DA - 2008// TI - Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data JO - Pharmacoepidemiol Drug Saf VL - 17 UR - https://doi.org/10.1002/pds.1518 DO - 10.1002/pds.1518 ID - Roumie2008 ER - TY - JOUR AU - Gage, B. F. AU - Waterman, A. D. AU - Shannon, W. AU - Boechler, M. AU - Rich, M. W. AU - Radford, M. J. PY - 2001 DA - 2001// TI - Validation of clinical classification schemes for predicting stroke : results from the National Registry of Atrial Fibrillation JO - JAMA VL - 285 UR - https://doi.org/10.1001/jama.285.22.2864 DO - 10.1001/jama.285.22.2864 ID - Gage2001 ER - TY - JOUR AU - Rothendler, J. A. AU - Rose, A. J. AU - Reisman, J. I. AU - Berlowitz, D. R. AU - Kazis, L. E. PY - 2012 DA - 2012// TI - Choices in the use of ICD-9 codes to identify stroke risk factor scan affects the apparent population-level risk factor prevalence and distribution of CHADS2 scores JO - Am J Cardiovasc Dis VL - 2 ID - Rothendler2012 ER - TY - JOUR AU - Rassen, J. A. AU - Solomon, D. H. AU - Curtis, J. R. AU - Herrinton, L. AU - Schneeweiss, S. PY - 2010 DA - 2010// TI - Privacy-maintaining propensity score-based pooling of multiple databases applied to a study of biologic JO - Med Care VL - 48 UR - https://doi.org/10.1097/MLR.0b013e3181d59541 DO - 10.1097/MLR.0b013e3181d59541 ID - Rassen2010 ER - TY - STD TI - Food and Drug Administration. FDA approves first protease inhibitor drug for treatment of HIV. Department of Health and Human Services. http://archive.hhs.gov/news/press/1995pres/951207.html. Accessed 4 Feb 2016. UR - http://archive.hhs.gov/news/press/1995pres/951207.html ID - ref14 ER - TY - STD TI - Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf. Accessed 4 Feb 2016. UR - https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf ID - ref15 ER - TY - JOUR AU - Stein, J. H. PY - 2003 DA - 2003// TI - Dyslipidemia in the era of HIV protease inhibitors JO - Prog Cardiovasc Dis VL - 45 UR - https://doi.org/10.1053/pcad.2003.3 DO - 10.1053/pcad.2003.3 ID - Stein2003 ER - TY - JOUR AU - Yusuf, S. AU - Hawken, S. AU - Ounuu, S. AU - Dans, T. AU - Avezum, A. AU - Lanas, F. PY - 2004 DA - 2004// TI - Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study JO - Lancet VL - 364 UR - https://doi.org/10.1016/S0140-6736(04)17018-9 DO - 10.1016/S0140-6736(04)17018-9 ID - Yusuf2004 ER - TY - JOUR AU - Worm, S. W. AU - Sabin, C. AU - Weber, R. AU - Reiss, P. AU - El-Sadr, W. AU - Dabis, F. PY - 2010 DA - 2010// TI - Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study JO - J Infect Dis VL - 201 UR - https://doi.org/10.1086/649897 DO - 10.1086/649897 ID - Worm2010 ER - TY - JOUR AU - Lang, S. AU - Mary-Krause, M. AU - Cotte, L. AU - Gilquin, J. AU - Partisani, M. AU - Simon, A. PY - 2010 DA - 2010// TI - Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case–control study nested within the French Hospital Database on HIV ANRS cohort CO4 JO - Arch Intern Med VL - 170 UR - https://doi.org/10.1001/archinternmed.2010.197 DO - 10.1001/archinternmed.2010.197 ID - Lang2010 ER - TY - JOUR AU - Vaughn, G. AU - Detels, R. PY - 2007 DA - 2007// TI - Protease inhibitors and cardiovascular disease: analysis of the Los Angeles County adult spectrum of disease cohort JO - AIDS Care VL - 19 UR - https://doi.org/10.1080/09540120701203329 DO - 10.1080/09540120701203329 ID - Vaughn2007 ER - TY - STD TI - Daftary M, Dutta A, Xue Z, von Wyl V, Young M, Bacon M, et al. Women’s Interagency HIV Study (WIHS): cardiovascular outcomes in women on PI therapy. Presented at The XV International AIDS Conference; July 11–16, 2004; Bangkok, Thailand. ID - ref21 ER - TY - STD TI - Holmberg SD, Moorman AC, Tong TC, Ward DJ, Wood KC, Greenberg AE, et al. Protease inhibitor drug use and adverse cardiovascular events in ambulatory HIV-infected patients. Presented at The XIV International AIDS Conference; July 7–12, 2002; Barcelona, Spain. ID - ref22 ER - TY - JOUR AU - Kwong, G. P. AU - Ghani, A. C. AU - Rode, R. A. AU - Bartley, L. M. AU - Cowling, B. J. AU - Silva, B. PY - 2006 DA - 2006// TI - Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use JO - AIDS VL - 20 UR - https://doi.org/10.1097/01.aids.0000247115.81832.a1 DO - 10.1097/01.aids.0000247115.81832.a1 ID - Kwong2006 ER - TY - JOUR AU - Iloeje, U. H. AU - Yuan, Y. AU - L’Italien, G. AU - Mauskopf, J. AU - Holmberg, S. D. AU - Moorman, A. C. PY - 2005 DA - 2005// TI - Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients JO - HIV Med VL - 6 UR - https://doi.org/10.1111/j.1468-1293.2005.00265.x DO - 10.1111/j.1468-1293.2005.00265.x ID - Iloeje2005 ER - TY - JOUR AU - Rickerts, V. AU - Brodt, H. AU - Staszewski, S. AU - Stille, W. PY - 2000 DA - 2000// TI - Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study JO - Eur J Med Res VL - 5 ID - Rickerts2000 ER - TY - STD TI - Triant V, Regan S, Lee H, Sax P, Meigs J, Grinspoon S. Association of antiretroviral therapy and HIV-related factors with acute myocardial infarction rates. Presented at The XVIII International AIDS Conference; July 18–23, 2010; Vienna, Austria. ID - ref26 ER - TY - JOUR AU - Goldberger, Z. D. AU - Valle, J. A. AU - Dandekar, V. K. AU - Chan, P. S. AU - Ko, D. T. AU - Nallamothu, B. K. PY - 2010 DA - 2010// TI - Are changes in carotid intima-media thickness related to risk of nonfatal myocardial infarction? A critical review and meta-regression analysis JO - Am Heart J VL - 160 UR - https://doi.org/10.1016/j.ahj.2010.06.029 DO - 10.1016/j.ahj.2010.06.029 ID - Goldberger2010 ER - TY - JOUR AU - Bedi, U. S. AU - Singh, M. AU - Singh, P. P. PY - 2010 DA - 2010// TI - Effects of statins on progression of carotid artherosclerosis as measured by carotid intimal—medial thickness: a meta-analysis of randomized controlled trials JO - J Cardiovasc Pharmacol Ther VL - 15 UR - https://doi.org/10.1177/1074248410369110 DO - 10.1177/1074248410369110 ID - Bedi2010 ER - TY - JOUR AU - Espeland, M. A. AU - O’leary, D. H. AU - Terry, J. G. AU - Morgan, T. AU - Evans, G. AU - Mudra, H. PY - 2005 DA - 2005// TI - Cartoid intimal-media thickness as a surrogate for cardiovascular disease events in trials of HMG-CoA reductase inhibitors JO - Curr Control Trials Cardiovasc Med VL - 6 UR - https://doi.org/10.1186/1468-6708-6-3 DO - 10.1186/1468-6708-6-3 ID - Espeland2005 ER - TY - JOUR AU - Laprise, C. AU - Baril, J. G. AU - Dufresne, S. AU - Trottier, H. PY - 2013 DA - 2013// TI - Atazanavir and other determinants of hyperbilirubinemia in a cohort of 1150 HIV-positive patients: results from 9 years of follow-up JO - AIDS Patient Care STDs VL - 27 UR - https://doi.org/10.1089/apc.2013.0009 DO - 10.1089/apc.2013.0009 ID - Laprise2013 ER - TY - JOUR AU - Tatami, Y. AU - Suzuki, S. AU - Ishii, H. AU - Shibata, Y. AU - Osugi, N. AU - Ota, T. PY - 2014 DA - 2014// TI - Impact of serum bilirubin levels on carotid atherosclerosis in patients with coronary artery disease JO - IJC Metab & Endocrine VL - 5 UR - https://doi.org/10.1016/j.ijcme.2014.08.006 DO - 10.1016/j.ijcme.2014.08.006 ID - Tatami2014 ER - TY - JOUR AU - Lin, J. P. AU - O’Donnell, C. J. AU - Schwaiger, J. P. PY - 2006 DA - 2006// TI - Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study JO - Circulation VL - 114 UR - https://doi.org/10.1161/CIRCULATIONAHA.106.633206 DO - 10.1161/CIRCULATIONAHA.106.633206 ID - Lin2006 ER - TY - JOUR AU - Vitek, L. AU - Jersa, M. AU - Brodanova, M. PY - 2002 DA - 2002// TI - Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels JO - Atherosclerosis VL - 160 UR - https://doi.org/10.1016/S0021-9150(01)00601-3 DO - 10.1016/S0021-9150(01)00601-3 ID - Vitek2002 ER - TY - JOUR AU - Cruciani, M. AU - Zanichelli, V. AU - Serpelloni, G. AU - Bosco, O. AU - Malena, M. AU - Mazzi, R. PY - 2011 DA - 2011// TI - Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data JO - AIDS VL - 25 UR - https://doi.org/10.1097/QAD.0b013e328349c6ee DO - 10.1097/QAD.0b013e328349c6ee ID - Cruciani2011 ER - TY - STD TI - Rosenblatt L, Farr AM, Johnston S, Nkhoma E. Risk of cardiovascular events in efavirenz-containing vs. efavirenz-free antiretroviral therapy. Presented at the 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention; July 19–22, 2015; Vancouver, Canada. ID - ref35 ER - TY - STD TI - Centre for Health & Infectious Disease Research. D:A:D participating cohorts. http://www.cphiv.dk/Ongoing-Studies/DAD/Study-Group. Accessed 4 Feb 2016. UR - http://www.cphiv.dk/Ongoing-Studies/DAD/Study-Group ID - ref36 ER -